Ebenezer O. Sackey

Array ( [id] => 12346581 [patent_doc_number] => 09951029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-24 [patent_title] => Styryl quinazoline derivatives as pharmaceutically active agents [patent_app_type] => utility [patent_app_number] => 14/911159 [patent_app_country] => US [patent_app_date] => 2014-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14335 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940013 [patent_doc_number] => 20140343033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'AZAINDOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/451254 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42812 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813109 [patent_doc_number] => 20150025055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/448578 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12328 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11225283 [patent_doc_number] => 09452997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Piperidine and piperazine derivatives as autotaxin inhibitors' [patent_app_type] => utility [patent_app_number] => 14/446484 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36679 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14446484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11198321 [patent_doc_number] => 09428522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Piperazines, pharmaceutical compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/445458 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 61428 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14445458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954593 [patent_doc_number] => 20140357616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'PYRROLOPYRIDINE INHIBITORS OF KINASES' [patent_app_type] => utility [patent_app_number] => 14/444540 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40267 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10343906 [patent_doc_number] => 20150228911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/338201 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12166096 [patent_doc_number] => 09884857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Salts of dasatinib in amorphous form' [patent_app_type] => utility [patent_app_number] => 14/906974 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6121 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14906974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10821979 [patent_doc_number] => 20160168143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'SALTS OF DASATINIB IN CRYSTALLINE FORM' [patent_app_type] => utility [patent_app_number] => 14/907148 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5856 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10267128 [patent_doc_number] => 20150152125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'SALTS OF ISOPHOSPHORAMIDE MUSTARD AND ANALOGS THEREOF AS ANTI-TUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 14/328125 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11953 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10979881 [patent_doc_number] => 20160176825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'KINASE INHIBITORS FOR THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 14/903650 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 28070 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932228 [patent_doc_number] => 20150080420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'AMORPHOUS FORM OF LOPINAVIR AND RITONAVIR MIXTURE' [patent_app_type] => utility [patent_app_number] => 14/319755 [patent_app_country] => US [patent_app_date] => 2014-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1861 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14319755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799063 [patent_doc_number] => 20160145219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI' [patent_app_type] => utility [patent_app_number] => 14/900214 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60931 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11773376 [patent_doc_number] => 09382214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Processes for the preparation of uracil derivatives' [patent_app_type] => utility [patent_app_number] => 14/309732 [patent_app_country] => US [patent_app_date] => 2014-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9583 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10805212 [patent_doc_number] => 20160151370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'Substituted Benzylpyrazoles' [patent_app_type] => utility [patent_app_number] => 14/900575 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30776 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10821966 [patent_doc_number] => 20160168130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'HETEROARYL SUBSTITUTED PYRAZOLES' [patent_app_type] => utility [patent_app_number] => 14/899418 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35274 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12437328 [patent_doc_number] => 09978960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Organometallic iridium complex, light-emitting element, light-emitting device, and lighting device [patent_app_type] => utility [patent_app_number] => 14/300695 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 15459 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14300695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776163 [patent_doc_number] => 20160122319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'CYCLIC AMINOMETHYL PYRIMIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 14/894402 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24247 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10978885 [patent_doc_number] => 20160175828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'N-HETEROCYCLIC CARBENE TYPE PALLADIUM CATALYST AND ITS PREPARATION METHOD AS WELL AS APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/910456 [patent_app_country] => US [patent_app_date] => 2014-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7389 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14700009 [patent_doc_number] => 10377738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Pyridone derivatives for the treatment of viral infections and further diseases [patent_app_type] => utility [patent_app_number] => 14/892701 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4348 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892701 [rel_patent_id] =>[rel_patent_doc_number] =>)